Application for authorisation fees adjusted

The European Commission has revised the fees for applications for authorisation of substances of very high concern under REACH. The revision encourages companies to apply together. The fees for additional uses have increased.

ECHA will continue to charge an unchanged base fee covering the application for an authorisation for one substance and one use. The revision of the Fee Regulation increases the fees charged for each additional use covered by the application.

The revised fees therefore take better account of the amount of work involved in assessing the applications. On the other hand, no fees will be charged for additional applicants. Therefore, joint applications are encouraged. If companies are of a different size, the highest applicable fee will be levied.

The revised fees will also apply to authorisation holders who submit a review report.



Related News